Cellnex, ES0105066007

Cellnex stock gets cash-flow lift as Poland reshapes outlook

Published on 11/12/2026 at 10:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cellnex stock benefits from stronger nine-month cash generation. Jefferies raised its target while the company kept its core guidance intact.

Cash generation meets capital discipline

  • Cellnex more than doubled free cash flow in the first nine months as operating efficiency and lower investment supported cash conversion.
  • The Poland programme adds near-term capital spending but is intended to improve co-location and long-term returns.
  • Jefferies raised its target while Cellnex kept its main 2026 guidance and 2027 leverage goal unchanged.
Cellnex, ES0105066007, Illustration mit AI erstellt.

Cellnex reported stronger cash generation for the first nine months of 2026 on November 5, while a new Polish infrastructure programme added a near-term investment trade-off. The company retained its main financial targets, and Jefferies subsequently lifted its price target.

According to Cellnex, free cash flow rose to 474 million euros in the nine months ended September 30, from 186 million euros a year earlier. Reported revenue excluding pass-through increased 2.4 percent to 3,008 million euros, while organic like-for-like revenue grew 4.9 percent.

The improvement came alongside tighter operating costs and lower growth investment. Like-for-like operating expenses fell 4.4 percent, or 22 million euros, despite a tower base that was approximately 2,900 sites larger. Growth investment declined 22 percent to 860 million euros from 1,114 million euros, helping the adjusted EBITDA margin expand to 84.8 percent from 83.1 percent.

Cash generation meets capital discipline

Operating profit increased to 410 million euros from 353 million euros. Recurring leveraged free cash flow rose 11.2 percent organically on a like-for-like basis to 1,390 million euros, while recurring leveraged free cash flow per share increased 18.3 percent to 2.09 euros.

Cellnex said net financial debt stood at 21,044 million euros on September 30. The net-debt-to-adjusted-EBITDA ratio improved to 6.13 times from 6.28 times at the end of 2025, and management maintained its target of reaching a 5-to-6-times leverage range in 2027.

Cellnex stock traded at 26.67 euros on Lang & Schwarz at 10:08:46 CET on Thursday, November 12, 2026.

Poland adds near-term pressure

The agreement with Polkomtel in Poland combines new co-locations, antenna relocations and site decommissioning. Cellnex plans 500 million euros of incremental capital expenditure between 2026 and 2030, with approximately 3,200 new co-locations expected by 2030 and a further 2,000 committed after that.

Management expects the programme to lift the tenancy ratio above two times by 2035 and generate a double-digit unlevered post-tax internal rate of return. The company also said the investment and accelerated Build-to-Suit deliveries would reduce 2027 like-for-like free cash flow by 300 million euros, while creating higher long-term revenue, EBITDA after leases and cash generation.

Analyst target and investor lens

ad-hoc-news.de reported that Jefferies raised its Cellnex price target from 34 euros to 35 euros and retained a Buy recommendation. The broker estimated that the Polish investment would leave 2027 free cash flow at 675 million to 875 million euros, all else equal.

The investment case therefore combines improving cash conversion with a temporary increase in capital intensity. For investors, the key test is whether higher co-location and network efficiency in Poland can offset the near-term cash-flow reduction while Cellnex continues to reduce leverage.

European telecommunications infrastructure shares remain sensitive to leverage, refinancing costs and demand for network capacity. The Euro Stoxx 50 provides the broader regional market backdrop.

Further company developments and analysis are available on More news and analyses on Cellnex stock.

Cellnex Telecom, S.A.

  • ISIN: ES0105066007
  • Ticker: CLNX.MC
  • Lang & Schwarz price: 26.67 euros at 10:08:46 CET on November 12, 2026
  • Nine-month free cash flow: 474 million euros through September 30, 2026
  • 2026 free cash flow guidance: 600 million to 700 million euros
Disclaimer...
en | ES0105066007 | CELLNEX | boerse | 70496547 | bgmi